Medilink UK, a professional membership association and specialist consultancy for the life sciences sector, has signed an agreement with the world-famous Medical Alley, to support medical device companies in the UK to unlock exciting opportunities in the US market through its Market Access Programme (MAP).   

Dr Rashmi Raju, International Manager at Medilink explained: “We are pleased to announce this strategic partnership with Medical Alley as part of Medilink’s Market Access programme (MAP), aimed at supporting medical device companies in navigating the complexities of global market access. This collaboration provides participants with invaluable insights into regulatory, reimbursement, and commercial pathways, strengthened by Medical Alley’s established MedTech network and expertise. Together, we look forward to fostering innovation, improving patient outcomes, and driving growth within the global healthcare ecosystem.”

The programme will take place over a three-week period, starting on the 17 February 2025. The first week includes online sessions delivered to participating companies in the UK. Week two consists of an online showcase pitch, providing companies with a platform to connect with potential contacts, key partners and valuable resources. Week three concludes the programme with a market visit to Minnesota, USA, where Medical Alley is headquartered.

Through this partnership, Medical Alley Starts® — a global venture platform which accelerates the formation and growth of healthcare startups — will deliver a customized U.S. Go-To-Market accelerator program for U.K. MedTech companies through Medilink. This tailored program will equip participants with critical knowledge in areas such as regulatory strategy, reimbursement pathways, market validation, and commercialisation. It also provides direct access to one-on-one connections with leaders and companies across Medical Alley’s extensive network.

Roberta Dressen, Medical Alley President and CEO added: “This partnership exemplifies our commitment to advancing global collaboration and innovation. By working closely with Medilink UK, we are excited to support UK medical device companies in navigating the U.S. market, empowering them to bring transformative technologies to patients worldwide.”

To help companies determine the suitability of the programme, and get the most from participation, Medilink and Medical Alley are offering individual consultations at which companies interested in taking part can meet market experts to discuss opportunities available. To find out more contact [email protected] or call 0114 232 9292.

Latest Opportunities

Exporting Starts Here programme for West Midlands companies

West Midlands Combined Authority (WMCA), funded by the UK Shared Prosperity Fund (UKSPF), has commissioned…

NIHR i4i Connect funding call

The NIHR Invention for Innovation (i4i) programme is accepting outline applications to their latest researcher-led Connect funding…

Study brief: The effects of a recovery gel on endurance cycling performance in the heat

The popularity of endurance sports like cycling and running has grown significantly over the past…

Latest News

Blog: Why cleanrooms are essential for medical-grade cannabis companies

By Medilink Midlands Member Airology Systems The demand for medical-grade cannabis has surged in recent…

Australia’s Cannim partners with PHTA to advance medicinal cannabis research

Leading medicinal cannabis company Cannim has announced its UK operations will be based at Birmingham’s…

New sleep trial shows dramatic benefits for participants

Cambridge Sleep Sciences (CSS), a leading UK innovator in sleep technology, has announced groundbreaking results…